Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Lung abnormalities completely resolve for majority of COVID pneumonia patients

A study published this week in Radiology found that 12 months after hospitalization for COVID pneumonia, 93% of patients’ lung abnormalities had cleared up on follow-up chest CT scans.

Thumbnail

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 

TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial,

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

Engineers have developed and tested a new wearable device capable of monitoring a person’s blood sugar, alcohol and lactate levels all at the same time, detailing their work in Nature Biomedical Engineering

Small wearable device monitors blood sugar, alcohol and lactate levels at the same time

Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.

Flu shots lower CVD risk, new meta-analysis confirms

The study's authors tracked data from six different randomized controlled trials, including a large study from 2021 that focused on myocardial infarction patients.

Kaiser Permanente reports nearly $1B loss over COVID surge

California-based health system Kaiser Permanente was slammed by a surge in COVID-19 cases during the first quarter of 2022, playing a role in a nearly $1 billion loss in the first three months of the year.

David Bennett

How did the pig heart transplant patient die? A preventable infection may be to blame

The genetically modified pig heart appears to have been infected with a porcine virus, according to the surgeon who performed the initial transplant. 

FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.